List of Tables
Table 1. Major Company of Blood Cancer
Table 2. Major Company of Breast Cancer
Table 3. Major Company of Gastrointestinal Cancer
Table 4. Major Company of Prostate Cancer
Table 5. Major Company of Others
Table 6. Global Oncology (Anti-cancer Drugs) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (K MT)
Table 8. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2018-2023)
Table 9. Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US& Million)
Table 10. Global Oncology (Anti-cancer Drugs) Market Share in Value by Type (2018-2023)
Table 11. Global Oncology (Anti-cancer Drugs) Price by Type (2018-2023) & (USD/MT)
Table 12. Global Oncology (Anti-cancer Drugs) Sales by Type (2024-2029) & (K MT)
Table 13. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type (2024-2029)
Table 14. Global Oncology (Anti-cancer Drugs) Sales by Type (2024-2029) & (US$ Million)
Table 15. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type (2024-2029)
Table 16. Global Oncology (Anti-cancer Drugs) Price by Type (2024-2029) & (USD/MT)
Table 17. North America Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (K MT)
Table 18. North America Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
Table 19. Europe Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
Table 20. Europe Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
Table 21. Asia-Pacific Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
Table 22. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
Table 23. Latin America Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
Table 24. Latin America Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
Table 25. Middle East and Africa Oncology (Anti-cancer Drugs) Sales (K MT) by Type (2018-2023)
Table 26. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Type (2018-2023) & (US$ Million)
Table 27. Global Oncology (Anti-cancer Drugs) Sales by Company (2018-2023) & (K MT)
Table 28. Global Oncology (Anti-cancer Drugs) Sales Share by Company (2018-2023)
Table 29. Global Oncology (Anti-cancer Drugs) Revenue by Company (2018-2023) & (US$ Million)
Table 30. Global Oncology (Anti-cancer Drugs) Revenue Share by Company (2018-2023)
Table 31. Global Market Oncology (Anti-cancer Drugs) Price by Company (2018-2023) & (USD/MT)
Table 32. Global Oncology (Anti-cancer Drugs) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Oncology (Anti-cancer Drugs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncology (Anti-cancer Drugs) as of 2022)
Table 35. Date of Key Manufacturers Enter into Oncology (Anti-cancer Drugs) Market
Table 36. Key Manufacturers Oncology (Anti-cancer Drugs) Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Oncology (Anti-cancer Drugs) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Global Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (K MT)
Table 40. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2018-2023)
Table 41. Global Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (US$ Million)
Table 42. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2018-2023)
Table 43. Global Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 44. Global Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (K MT)
Table 45. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2024-2029)
Table 46. Global Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (US$ Million)
Table 47. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2024-2029)
Table 48. Global Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2029)
Table 49. Global Oncology (Anti-cancer Drugs) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 50. Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (K MT)
Table 51. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2018-2023)
Table 52. Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
Table 53. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2018-2023)
Table 54. Global Oncology (Anti-cancer Drugs) Price by Application (2018-2023) & (USD/MT)
Table 55. Global Oncology (Anti-cancer Drugs) Sales by Application (2024-2029) & (K MT)
Table 56. Global Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application (2024-2029)
Table 57. Global Oncology (Anti-cancer Drugs) Sales by Application (2024-2029) & (US$ Million)
Table 58. Global Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application (2024-2029)
Table 59. Global Oncology (Anti-cancer Drugs) Price by Application (2024-2029) & (USD/MT)
Table 60. North America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
Table 61. North America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
Table 62. Europe Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
Table 63. Europe Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
Table 64. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
Table 65. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
Table 66. Latin America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
Table 67. Latin America Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
Table 68. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) (K MT)
Table 69. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Application (2018-2023) & (US$ Million)
Table 70. North America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 71. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
Table 72. North America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
Table 73. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
Table 74. North America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 75. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
Table 76. North America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
Table 77. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
Table 78. Europe Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 79. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
Table 80. Europe Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
Table 81. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
Table 82. Europe Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 83. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
Table 84. Europe Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
Table 85. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
Table 86. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (K MT)
Table 87. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2018-2023)
Table 88. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2018-2023) & (US$ Million)
Table 89. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2018-2023)
Table 90. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (K MT)
Table 91. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Region (2024-2029)
Table 92. Asia-Pacific Oncology (Anti-cancer Drugs) Sales by Region (2024-2029) & (US$ Million)
Table 93. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Region (2024-2029)
Table 94. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 95. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
Table 96. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
Table 97. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
Table 98. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 99. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
Table 100. Latin America Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
Table 101. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
Table 102. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (K MT)
Table 103. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2018-2023)
Table 104. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2018-2023) & (US$ Million)
Table 105. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2018-2023)
Table 106. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (K MT)
Table 107. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Country (2024-2029)
Table 108. Middle East and Africa Oncology (Anti-cancer Drugs) Sales by Country (2024-2029) & (US$ Million)
Table 109. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Country (2024-2029)
Table 110. Roche Company Information
Table 111. Roche Introduction and Business Overview
Table 112. Roche Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 113. Roche Oncology (Anti-cancer Drugs) Product
Table 114. Roche Recent Development
Table 115. Novartis Company Information
Table 116. Novartis Introduction and Business Overview
Table 117. Novartis Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 118. Novartis Oncology (Anti-cancer Drugs) Product
Table 119. Novartis Recent Development
Table 120. Celgene Company Information
Table 121. Celgene Introduction and Business Overview
Table 122. Celgene Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 123. Celgene Oncology (Anti-cancer Drugs) Product
Table 124. Celgene Recent Development
Table 125. Amgen Company Information
Table 126. Amgen Introduction and Business Overview
Table 127. Amgen Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 128. Amgen Oncology (Anti-cancer Drugs) Product
Table 129. Amgen Recent Development
Table 130. Johnson & Johnson Company Information
Table 131. Johnson & Johnson Introduction and Business Overview
Table 132. Johnson & Johnson Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 133. Johnson & Johnson Oncology (Anti-cancer Drugs) Product
Table 134. Johnson & Johnson Recent Development
Table 135. GlaxoSmithKline Company Information
Table 136. GlaxoSmithKline Introduction and Business Overview
Table 137. GlaxoSmithKline Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 138. GlaxoSmithKline Oncology (Anti-cancer Drugs) Product
Table 139. GlaxoSmithKline Recent Development
Table 140. Eli lilly & Co Company Information
Table 141. Eli lilly & Co Introduction and Business Overview
Table 142. Eli lilly & Co Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 143. Eli lilly & Co Oncology (Anti-cancer Drugs) Product
Table 144. Eli lilly & Co Recent Development
Table 145. Pfizer Company Information
Table 146. Pfizer Introduction and Business Overview
Table 147. Pfizer Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 148. Pfizer Oncology (Anti-cancer Drugs) Product
Table 149. Pfizer Recent Development
Table 150. Merck & Co. Company Information
Table 151. Merck & Co. Introduction and Business Overview
Table 152. Merck & Co. Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 153. Merck & Co. Oncology (Anti-cancer Drugs) Product
Table 154. Merck & Co. Recent Development
Table 155. Sanofi Company Information
Table 156. Sanofi Introduction and Business Overview
Table 157. Sanofi Oncology (Anti-cancer Drugs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 158. Sanofi Oncology (Anti-cancer Drugs) Product
Table 159. Sanofi Recent Development
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Oncology (Anti-cancer Drugs) Market Trends
Table 163. Oncology (Anti-cancer Drugs) Market Drivers
Table 164. Oncology (Anti-cancer Drugs) Market Challenges
Table 165. Oncology (Anti-cancer Drugs) Market Restraints
Table 166. Oncology (Anti-cancer Drugs) Distributors List
Table 167. Oncology (Anti-cancer Drugs) Downstream Customers
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncology (Anti-cancer Drugs) Product Picture
Figure 2. Global Oncology (Anti-cancer Drugs) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Oncology (Anti-cancer Drugs) Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Oncology (Anti-cancer Drugs) Sales Status and Outlook (2018-2029) & (K MT)
Figure 5. Product Picture of Blood Cancer
Figure 6. Global Blood Cancer Sales YoY Growth (2018-2029) & (K MT)
Figure 7. Product Picture of Breast Cancer
Figure 8. Global Breast Cancer Sales YoY Growth (2018-2029) & (K MT)
Figure 9. Product Picture of Gastrointestinal Cancer
Figure 10. Global Gastrointestinal Cancer Sales YoY Growth (2018-2029) & (K MT)
Figure 11. Product Picture of Prostate Cancer
Figure 12. Global Prostate Cancer Sales YoY Growth (2018-2029) & (K MT)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2029) & (K MT)
Figure 15. Global Oncology (Anti-cancer Drugs) Sales by Type (2018-2029) & (US$ Million)
Figure 16. Global Oncology (Anti-cancer Drugs) Sales Market Share by Type in 2022 & 2029
Figure 17. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
Figure 18. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
Figure 19. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
Figure 20. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
Figure 23. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology (Anti-cancer Drugs) Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Oncology (Anti-cancer Drugs) Revenue in 2022
Figure 29. Oncology (Anti-cancer Drugs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Chemotherapy
Figure 31. Global Chemotherapy Sales YoY Growth (2018-2029) & (K MT)
Figure 32. Product Picture of Targeted Therapy
Figure 33. Global Targeted Therapy Sales YoY Growth (2018-2029) & (K MT)
Figure 34. Product Picture of Immunotherapy (Biologic Therapy)
Figure 35. Global Immunotherapy (Biologic Therapy) Sales YoY Growth (2018-2029) & (K MT)
Figure 36. Product Picture of Hormonal Therapy
Figure 37. Global Hormonal Therapy Sales YoY Growth (2018-2029) & (K MT)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2029) & (K MT)
Figure 40. Global Oncology (Anti-cancer Drugs) Sales by Application (2018-2029) & (US$ Million)
Figure 41. Global Oncology (Anti-cancer Drugs) Sales Market Share by Application in 2022 & 2029
Figure 42. North America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
Figure 43. North America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
Figure 44. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
Figure 45. Europe Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
Figure 48. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Oncology (Anti-cancer Drugs) Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Oncology (Anti-cancer Drugs) Manufacturing Cost Structure
Figure 53. Oncology (Anti-cancer Drugs) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed